Abstract
Background: We evaluated the effectiveness of VATS in the diagnosis and palliative treatment of recurrent neoplastic pleural effusions. Methods: From 1987 to 2001, we performed 325 VATS chemical pleurodesis for malignant pleural effusions. We used talc in 253 subjects (78 %) and alcohol in 72 (22 %) as the sclerosant agent. In 226 patients (68 %) we performed biopsies because the histology was unknown. Results: Mean operating time was 33.38 ± 9.77 minutes (median: 32; range: 19 - 58), and the mean duration of chest intubation was 3.78 ± 1.33 days (median: 4; range 2 - 8). Complications occurred in 2 % of patients. Thirty-day mortality was 2 %. Mean postoperative inhospital stay was 5.53 ± 1.90 days (median 6; range: 2 - 11). We obtained 264 (81 %) therapeutic successes (no effusion recurrence within 4 months), and 55 relapses of which 32 had talc insufflation (13 % of talc group) and 23 alcohol instillation (32 % of alcohol group). Conclusions: VATS chemical pleurodesis is a safe, useful, versatile procedure for oncological pleural effusion management. The use of talc rather than alcohol significantly increased the therapeutic success rate. VATS should be considered the treatment of choice in patients with advanced neoplasm to obtain good palliation and a better quality of life.
Key words
Neoplastic pleural effusion - diagnostic assessment - palliative treatment - pleurodesis - video-assisted thoracoscopic surgery (VATS)
References
-
1
Glazer M, Borkman N, Lafair J S, Kramer M R.
Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion.
Chest.
2000;
117
1404-1409
-
2
Antony W B, Loddenkemper R, Astoul P. et al .
Management of malignant pleural effusions.
Eur Respir J.
2001;
18
402-419
-
3
Waller D A, Morritt G N, Forty J.
Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.
Chest.
1995;
107
1454-1456
-
4
Ross R T, Burnett C M.
Talc pleurodesis: a new technique.
Am Surg.
2001;
67
467-468
-
5
Cardillo G, Facciolo F, Carbone L. et al .
Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.
Eur J Cardio-Thorac Surg.
2002;
21
302-305
-
6
Yim A PC, Chan A TC, Lee T W, Wan I YP, Ho J KS.
Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusions.
Ann Thorac Surg.
1996;
62
1655-1658
-
7
Macha H N, Reichle G, von Zwehl D, Kemmer H P, Bas R, Morgan J A.
The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease.
Eur J Cardio-Thorac Surg.
1993;
7
19-22
-
8
De Campos J R, Vargas F S, De Campos Werebe E. et al .
Thoracoscopy talc poudrage: a 15-year experience.
Chest.
2001;
119
801-806
-
9
Brega Massone P P, Conti B, Magnani B, Lequaglie C, Cataldo I.
Video-assisted thoracoscopic surgery for diagnosis, staging and management of lung cancer with suspected mediastinal lymphadenopathy.
Surg Laparosc Endosc Percutan Tech.
2002;
12
104-109
-
10
Viallat J R, Rey F, Astoul P, Boutin C.
Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.
Chest.
1996;
110
1387-1393
-
11
Menzies R, Charbonneau M.
Thoracoscopy for the diagnosis of pleural disease.
Ann Intern Med.
1991;
114
271-276
-
12
Petrakis I, Katsamouris A, Drossitis I, Chalkiadakis G.
Video-assisted thoracoscopic surgery in the diagnosis and treatment of chest diseases.
Surg Laparosc Endosc Percutan Tech.
2002;
12
104-109
-
13
Petrou M, Kaplan D, Goldstraw P.
Management of recurrent malignant pleural effusions. The complementary role of talc pleurodesis and pleuroperitoneal shunt.
Cancer.
1995;
75
801-805
-
14
Mager H J, Maesen B, Verzijlbergen F, Schramel F.
Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis.
Lung Cancer.
2002;
36
77-81
-
15
Schulze M, Boehle A S, Kurdow R, Dohrmann P, Henne-Bruns D.
Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunt in 101 patients.
Ann Thorac Surg.
2001;
71
1809-1812
-
16
Genc O, Petrou M, Ladas G, Goldstraw P.
The long-term morbidity of pleuroperitoneal shunt in the management of recurrent malignant pleural effusion.
Eur J Cardio Thorac Surg.
2000;
18
143-146
-
17
Parekh K, Rusch V, Bains M, Downey R, Ginsberg R.
VATS port site recurrence: a technique dependent problem.
Ann Surg Oncol.
2001;
8
175-178
-
18
Mutsaerts E L, Zoetmulder F A, Rutgers E J.
Port site metastasis as a complication of thoracoscopic metastasectomy.
Eur J Surg Oncol.
2001;
27
327-328
-
19
Diacon A H, Wyser C, Bolliger C T. et al .
Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.
Am J Respir Crit Care Med.
2000;
162
1445-1449
-
20
Allen M SA, Deschamps C, Jones D M, Trastek V F, Paroleiro P C.
Video-assisted thoracic surgical procedures: the Mayo experience.
Mayo Clin Proc.
1996;
71
351-359
-
21
Ghio A J, Roggli V, Light R W.
Talc should not be used for pleurodesis in patients with nonmalignant pleural effusions.
Am J Respir Crit Care Med.
2001;
164
1741
-
22
Ong K C, Indumathi V, Raughuram J, Ong V Y.
A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.
Respirology.
2000;
5
99-103
-
23
Brant A, Eaton T.
Serious complications with talc slurry.
Respirology.
2001;
6
181-185
-
24
Light R W.
Management of pleural effusions.
J Formos Med Assoc.
2000;
99
523-531
-
25
Shoji T, Tanaka F, Yanagihara K, Inui K, Wada H.
Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion.
Chest.
2002;
121
821-824
1 The abstract was selected and presented at the EACTS/ESTS Joint Meeting 2001. Lisbon (Portugal), September 16 - 19, 2001
Dr. P. P. Brega-Massone
Oncologic Thoracic Surgery · National Cancer Institute Milan
Via Cascina Spelta, 24/b
27100 Pavia
Italy
Telefon: + 39(02)23902384
Fax: + 39 (02) 2 36 04 86
eMail: ppbm@virgilio.it
